ProPhase Labs, Inc. logo

ProPhase Labs, Inc.

NASDAQ:PRPH

Overview | Financials
Company Name ProPhase Labs, Inc.
Symbol PRPH
Currency USD
Price 2.51
Market Cap 47,887,035
Dividend Yield 0%
52-week-range 2.04 - 7.48
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Ted William Karkus
Website https://www.prophaselabs.com

An error occurred while fetching data.

About ProPhase Labs, Inc.

ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Legendz XL

Related Stocks

Sol-Gel Technologies Ltd. logo

Sol-Gel Technologies Ltd.

SLGL

0.702 USD

AVITA Medical, Inc. logo

AVITA Medical, Inc.

RCEL

9.96 USD

PDS Biotechnology Corporation logo

PDS Biotechnology Corporation

PDSB

3.21 USD

Spok Holdings, Inc. logo

Spok Holdings, Inc.

SPOK

15.35 USD

Ikena Oncology, Inc. logo

Ikena Oncology, Inc.

IKNA

1.71 USD

scPharmaceuticals Inc. logo

scPharmaceuticals Inc.

SCPH

5.26 USD

Acumen Pharmaceuticals, Inc. logo

Acumen Pharmaceuticals, Inc.

ABOS

2.58 USD

Financials

Numbers are in millions USD

Numbers are in millions USD